Bayhill Therapeutics
Bayhill Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company uses its therapeutic BHT-DNA platform to develop a pipeline of treatment candidates for autoimmune diseases.
Bayhill Therapeutics People (First 5 people) - Page 0
William H. Robinson
Professor
Hideki Garren
Author
Lawrence Steinman
Academic
Paul J. Utz
Professor
